Literature DB >> 23569894

Immunological effect of aqueous extract of Vernonia amygdalina and a known immune booster called immunace(®) and their admixtures on HIV/AIDS clients: a comparative study.

M A Momoh1, U Muhamed, A A Agboke, E I Akpabio, Uduma Eke Osonwa.   

Abstract

OBJECTIVE: To investigate the immunological effect of Vernonia amygdalina (V. amygdalina) leaf extract and immunace(®) on HIV infected patients taking highly active antiretroviral therapy.
METHODS: Fresh V. amygdalina leaves were collected within Nsukka area in Enugu State. The leaves were rinsed with distilled water. Two handful of cleaned fresh leaves were soaked in 200 mL water and squeezed gently by hand to a mixture. Clients were divided into four groups and each group was given different combination. They took the medication for four weeks. The immune effect was tested against marketed immune booster in some retroviral clients.
RESULTS: The mean absolute CD4 count was increased in the client who took the extract or supplement. And the clients who took both the extract and supplement had a greater increase in the CD4 count. The increased CD4 was significant as compared with the control group (P<0.05). The skin rashes were also improved in the entire groups.
CONCLUSIONS: It can be concluded that the aqueous extract of V. amygdalina and immunace or both have immunological effect on HIV infected patients. Therefore, we suggest that the V. amygdalina extract or immunace or both could be used as adjuvant in the management of HIV/AIDS clients.

Entities:  

Keywords:  Antiretroviral therapy; CD4+ cell; HIV/AIDS; Immunace®; Immune; Immunological effect; Vernonia amygdalina

Mesh:

Substances:

Year:  2012        PMID: 23569894      PMCID: PMC3609274          DOI: 10.1016/S2221-1691(12)60038-0

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  12 in total

Review 1.  Human immunodeficiency virus type 2.

Authors:  Jacqueline D Reeves; Robert W Doms
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

2.  Virological and immunological effects of antioxidant treatment in patients with HIV infection.

Authors:  F Müller; A M Svardal; I Nordoy; R K Berge; P Aukrust; S S Frøland
Journal:  Eur J Clin Invest       Date:  2000-10       Impact factor: 4.686

3.  Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Authors:  Nancy F Crum; Robert H Riffenburgh; Scott Wegner; Brian K Agan; Sybil A Tasker; Katherine M Spooner; Adam W Armstrong; Susan Fraser; Mark R Wallace
Journal:  J Acquir Immune Defic Syndr       Date:  2006-02-01       Impact factor: 3.731

4.  The HIV-AIDS pandemic at 25--the global response.

Authors:  Michael H Merson
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 5.  Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

Authors:  T A Springer
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

6.  Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria.

Authors:  Ernest B Izevbigie
Journal:  Exp Biol Med (Maywood)       Date:  2003-03

7.  Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals.

Authors:  J M Raboud; L Haley; J S Montaner; C Murphy; M Januszewska; M T Schechter
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995

Review 8.  Transient intercellular adhesion: the importance of weak protein-protein interactions.

Authors:  P A van der Merwe; A N Barclay
Journal:  Trends Biochem Sci       Date:  1994-09       Impact factor: 13.807

Review 9.  Dietary flavonoids: bioavailability, metabolic effects, and safety.

Authors:  Julie A Ross; Christine M Kasum
Journal:  Annu Rev Nutr       Date:  2002-01-04       Impact factor: 11.848

10.  Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.

Authors:  N M Graham; L P Park; S Piantadosi; J P Phair; J Mellors; J L Fahey; A J Saah
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more
  4 in total

1.  Medicinal plants used for the management of respiratory diseases in Zimbabwe: Review and perspectives potential management of COVID-19.

Authors:  Elliot Nyagumbo; William Pote; Bridgett Shopo; Trust Nyirenda; Ignatius Chagonda; Ruvimbo J Mapaya; Fabian Maunganidze; William N Mavengere; Cephas Mawere; Ian Mutasa; Emmanuel Kademeteme; Alfred Maroyi; Tafadzwa Taderera; Michael Bhebhe
Journal:  Phys Chem Earth (2002)       Date:  2022-09-21       Impact factor: 3.311

2.  Protective effects of Vernonia amygdalina against sodium arsenite-induced genotoxicity in rat.

Authors:  Adewale Adetutu; Emmanuel Bukoye Oyewo; Ayoade A Adesokan
Journal:  Pharmacognosy Res       Date:  2013-07

3.  Medicinal Plants in COVID-19: Potential and Limitations.

Authors:  Xin Yi Lim; Bee Ping Teh; Terence Yew Chin Tan
Journal:  Front Pharmacol       Date:  2021-03-24       Impact factor: 5.810

4.  Recent perspectives on the anticancer properties of aqueous extracts of Nigerian Vernonia amygdalina.

Authors:  Carolyn Bingham Howard; William K Johnson; Shehla Pervin; Ernest B Izevbigie
Journal:  Botanics       Date:  2015-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.